Pineapple juice labeled with gadolinium: A convenient oral contrast for magnetic resonance cholangiopancreatography

European Radiology

Volumn 15, Issue 10, 2005, Pages 2122-2129

  Coppens, Emmanuel ^a   Metens, Thierry ^a   Winant, Catherine ^a   Matos, Celso ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Contrast agents; Gadolinium; MR bile ducts; MR pancreatic ducts; MR rapid imaging

Indexed keywords

GADOTERIC ACID;

ARTICLE; BILIARY TRACT DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PANCREAS DISEASE; PINEAPPLE JUICE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

ADMINISTRATION, ORAL; ANANAS; BEVERAGES; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; COMMON BILE DUCT; CONTRAST MEDIA; DUODENUM; FEMALE; HEPATIC DUCT, COMMON; HETEROCYCLIC COMPOUNDS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MUSCLE RELAXATION; ORGANOMETALLIC COMPOUNDS; PANCREATIC DUCTS; PLANT PREPARATIONS; RADIOGRAPHIC IMAGE ENHANCEMENT; REPRODUCIBILITY OF RESULTS; STOMACH;

EID: 26044475923     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-005-2835-5     Document Type: Article

References (30)

1. Barish MA, Yucel EK, Ferrucci JT (1999) Magnetic resonance cholangiopancreatography. N Engl J Med 341:258-264 1:STN:280:DyaK1MzivVCqug%3D%3D
2. Devière J, Matos C, Cremer M (1999) The impact of magnetic resonance cholangiopancreatography on ERCP (editorial). Gastrointest Endosc 50:136-140 10385745
3. Holzknecht N, Ganger J, Sackmann M et al (1998) Breath-hold MR cholangiography with snapshot techniques: Prospective comparison with endoscopic retrograde cholangiography. Radiology 206:657-664 1:STN:280:DyaK1c7lsFGrtQ%3D%3D
4. Matos C, Metens T, Devière J et al (1997) Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology 203:435-441 1:STN:280:ByiB28fnsFc%3D
5. Hirohashi S, Hirohashi R, Uchida H et al (1997) MR cholangiopancreatography and MR urography: Improved enhancement with a negative oral contrast agent. Radiology 203:281-285 1:STN:280:ByiB3s3ktlM%3D
6. Hiraishi K, Narabayashi I, Fujita O et al (1995) Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging. Radiology 194:119-125 1:STN:280:ByqD1M%2FgvFE%3D
7. Papanikolaou N, Karantanas A, Maris T, Gourtsoyannis N (2000) MR cholangiopancreatography before and after oral blueberry juice administration. J Comput Assist Tomogr 24:229-234 1:STN:280:DC%2BD3c3hsVGmtQ%3D%3D
8. Chan JH, Tsui EY, Yuen MK, Szeto ML, Luk SH, Wong KP, Wong NO (2000) Gadopentate dimeglumine as an oral negative gastrointestinal agent for MRCP. Abdom Imaging 25:405-408 1:STN:280:DC%2BD3M%2Fjs1CqtA%3D%3D
9. Albrich H, Herfarth HH, Schreyer AG et al (2000) Tasty, cost-effective and healthy: Abdominal MRI in patients with IBD with a new oral contrast agent. Gastroenterology 118:A1077
10. Schreyer AG, Herfarth HH, Kikinis R, Seitz J, Schölmerich J, Geissler A, Feuerbach S (2002) 3D modeling and virtual endoscopy of the small bowel based on magnetic resonance imaging in patients with inflammatory bowel disease. Invest Radiol 37:528-533 12218449
11. In Den Kleef JJE, Cuppen JJM (1987) RLSQ: T1, T2, and ρ calculations, combining ratios and least squares. Magn Reson Med 5:513-524 1:STN:280:BieC2c3kt1M%3D
12. Meiboom S, Gill D (1958) Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instrum 29:688-691 1:CAS:528:DyaF3cXosFWitQ%3D%3D
13. Carr HY, Purcell EM (1954) Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev 94:630-638 1:CAS:528:DyaG2cXksFKjtA%3D%3D
14. Cappeliez O, Delhaye M, Devière J et al (2000) Chronic pancreatitis: Evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 215:358-364 1:STN:280:DC%2BD3c3ls12ktg%3D%3D
15. Mathur-De Vrè R, Lemort M (1995) Invited review: Biophysical properties and clinical applications of magnetic resonance imaging contrast agents. Br J Radiol 68:225-247 7735761
16. Van Gansbeke D, Metens TM, Matos C, Nicaise N, Gay F, Raeymaekers H, Struyven J (1997) Effect of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: Implications for tumor characterization. J Magn Reson Imaging 7:482-489 9170031
17. Punwani S, Gillams AR, Lees WR (2003) Non-invasive quantification of pancreatic exocrine function using secretin-stimulated MRCP. Eur Radiol 13:273-276 1:STN:280:DC%2BD3s%2Fos1ymsQ%3D%3D
18. Sujita R, Nomiya T (2002) Disappearance of the common bile duct signal caused by oral negative contrast agent on MR-cholangiopancreatography. J Comput Assist Tomogr 26:448-450 12016378
19. Karantanas AH, Papanikolaou N, Kalef-Ezra J, Challa A, Gourtsoyiannis N (2000) Blueberry juice used per os in upper abdominal MR imaging: composition and initial clinical data. Eur Radiol 10:909-913 1:STN:280:DC%2BD3cvotFGhsA%3D%3D
20. Riordan RD, Khonsari M, Jeffries J, Maskell GF, Cook PG (2004) Pineapple juice as negative oral contrast agent in magnetic resonance cholangiopancreatography: A preliminary evaluation. Br J Radiol 77:991-999 1:STN:280:DC%2BD2crpsFOiuw%3D%3D
21. Patak MA, Weishaupt D, Fröhlich JM, Debatin JF (1999) Sequential fast 3D MRI following oral ingestion of Gd-DOTA: A new means to assess intestinal transit time. J Magn Reson Imaging 10:474-476 1:STN:280:DyaK1Mvjsl2gtw%3D%3D
22. Luboldt W, Kienzler D, Seemann M et al (2000) Synergistic effect between iron and gadolinium in MRI. J Magn Reson Imaging 12:358-362 1:STN:280:DC%2BD3cvlsV2lsA%3D%3D
23. Allard M, Doucet D, Kien P, Bonnemain B, Caillé' JM (1988) Experimental study of DOTA-gadolinium: Pharmacokinetics and pharmacologic properties. Invest Radiol 23:S271-S274 1:CAS:528:DyaL1MXjs1WrsA%3D%3D
24. Schwizer W, Fraser R, Maecke H, Siebold K, Funck R, Fried M (1994) Gd-DOTA as a gastrointestinal contrast agent for gastric emtpying measurements with MRI. Magn Reson Med 31:388-393 1:STN:280:ByuB28fivFU%3D
25. Kunz P, Crelier GR, Schwizer W, Borovicka J, Kreiss C, Fried M, Boesiger P (1998) Gastric emptying and motility: Assessment with MR imaging - preliminary observations. Radiology 207:33-40 1:STN:280:DyaK1c7ptFeksA%3D%3D
26. Schmid MR, Hany TF, Knesplova L, Schlumpf R, Debatin JF (1999) 3D MR gastrography: Exoscopic an endoscopic analysis of the stomach. Eur Radiol 9:73-77 1:STN:280:DyaK1M7jt1Crug%3D%3D
27. Lauenstein TC, Goehde SC, Debatin JF (2002) Fecal tagging: MR colonography without colonic cleansing. Abdom Imaging 27:410-417 1:STN:280:DC%2BD38zit1alsQ%3D%3D
28. Tweedle MF (1992) Physicochemical properties of Gadoteridol and other magnetic resonance contrast agents. Invest Radiol 27:S2-S6 1506149
29. Cacheris WP, Quay SC, Rocklage SM (1990) The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 8:467-481 1:CAS:528:DyaK3MXit1aqtrc%3D
30. Weinmann H, Brasch R, Press W, Wesbey G (1984) Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent. Am J Roentgenol 142:619-624 1:STN:280:BiuC38vot1Q%3D